[ApolloF]

Why

A release audit (#19) found two level-model problems. Analysis:

1. Basic model exposure grows with half-life. The sheet's Basic peak (14·M·F·0.875) doesn't depend on t½, so one dose's area under the curve is ∝ t½ (AUC/F = 20.71·M·t½). Per mg of hormone, Tren E showed 7.3× Tren A's exposure, Parabolan 5.3×, Masteron E 2.25× Masteron P, Test Dec 1.9× the study-based testosterone esters. The ester only sets the release rate, so the same mg of hormone should give the same exposure.

2. Telmisartan Cmax is the average of a nonlinear pair. The sheet's 7.70 ng/mL per mg = mean per mg of the two arms of PMID 17009837 (40 mg: 163.2 ng/mL, 80 mg: 905.7 ng/mL; supraproportional per label). Linear use gave 1.9× too high at 40 mg (308 vs 163 ng/mL).

Also checked: retatrutide's sheet values are the exact means of the six Coskun 2022 (Cell Metab, Table 1) arms (Cmax 114.95 ng/mL per mg, t½ 147 h, Tmax 40 h); tirzepatide = 874 ng/mL at 15 mg, t½ 116.7 h. No change.

What

• SheetRow.exposureAnchors: Basic esters anchored to their hormone's reference: Test PP/Iso/Dec → mean of Test E/C/P; Tren E, Parabolan → Tren A; Masteron E → Masteron P. Peak set so AUC per mg hormone equals the anchors' mean; t½, Tmax, rise unchanged. Test Iso's 0.6 multiplier is replaced. Not anchored: Tren A, Masteron P (family anchors), Primobolan Depot, DHB, estradiol valerate (sheet-calibrated multipliers), MENT, orals, SARMs.
• Telmisartan multiplier 163.2/40/7.700625 = 0.5298 → 4.08 ng/mL per mg (40 mg arm, the usual dose). Underestimates 80 mg ~2.8×.
• Presets.VERSION → presets-2026-10d. PresetMigration upgrades log snapshots / edited presets holding the exact v0.6.0 (-10c) kinetics of the 7 changed presets (checked against a real v0.6.0 backup).
• docs/MODELS.md: anchoring section, tables, telmisartan note, limitations (Deca ≈1.85× NPP and Nebido ≈1.75× Test E per mg hormone remain; both study-based).

Steady state, avg (trough–peak) ng/dL	10c	10d
Tren E 100 mg / 3.5 d	4,622 (4,487–4,687)	630 (612–639)
Parabolan 75 mg / 3.5 d	2,344 (2,218–2,396)	439 (416–449)
Masteron E 400 mg/wk	3,888 (2,391–5,420)	1,728 (1,062–2,409)
Test Dec 250 mg/wk	2,693 (1,872–3,433)	1,379 (959–1,759)
Telmisartan 40 mg once (peak, ng/mL)	308	163

Tests

• New BasicExposureTest: equal exposure per mg hormone (closed form 1e-9 and numeric integration 0.5 %), ratios ≈ 1, unanchored rows keep the plain peak, anchors same hormone.
• PresetMigrationTest: 10c → 10d for Tren E, Test Dec, telmisartan (exact v0.6.0 values); edited copies stay. PresetsTest: telmisartan 40 mg peaks at 163.2 ng/mL.
• PkSheetGoldenTest: Tren E and Test Iso references scaled by exact peak ratio (3/22, 1.5426172); others unchanged.
• ./gradlew :core:domain:test passes locally. No app/ or resource changes.

Note for release notes

A user who set Adjust level on Trenbolone or Drostanolone to tame the old curve will now see it applied on top of the lower curve.